← Open Payments lookup

MEGAN TUMINELLO: Open Payments

NPI 1043632367 · GONZALES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$394 in 18 payments from 9 companies in 2025. Trend: 2023 $422 · 2024 $584 · 2025 $394

Food & beverage: $394
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.5$135
Otsuka America Pharmaceutical, Inc.4$74
E.R. Squibb & Sons, L.L.C.2$40
Janssen Pharmaceuticals, Inc2$40
Neurocrine BioSciences, Inc.1$31
Alkermes, Inc.1$21
Vanda Pharmaceuticals Inc.1$20
ABBVIE INC.1$17
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$14

Products named: UZEDY, ABILIFY ASIMTUFII, COBENFY, INVEGA SUSTENNA, INGREZZA, REXULTI, ARISTADA, FANAPT.

Industry payments across LA — which companies pay providers there.